News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 26, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) will be exhibiting it's patented CaverStemTM stem cell procedure for erectile dysfunction at the annual American Urological Association...
-
Feb 20, 2018CerebroStem LLC to Develop Patented Stem Cell Approaches to Treat Brain Damage
Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of CerebroStem LLC, a majority owned subsidiary focused on developing stem cell therapies for brain injuries and...
-
Dec 20, 2017
Creative Medical Technology Holdings, Inc (OTCQB:CELZ) provides the following discussion on a recent US News and World Report article[1] addressing advances of adult stem cells and its own...
-
Dec 18, 2017
Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today initiation of patient treatments using its patented Caverstem™ procedure by Dr. Alexander Gershman. Dr....
-
Dec 14, 2017
Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today recruitment of leading urologists in the Southwestern United States to perform its patented CaverstemTM...
-
Oct 19, 2017Trial Results Support Initiation of Urologist Outreach and Commercialization
Creative Medical Technology Holdings (OTCQB – CELZ) announced today completion of the safety data analysis on 20 patients with pharmacologically-resistant erectile dysfunction treated with the...
-
Oct 16, 2017Regenerative Medicine Company Files Patent on Practice of Medicine Procedure to Address Stroke
Creative Medical Technology Holdings (OTCQB: CELZ) announced today filing of a patent application using a combination of an FDA approved drug together with the patient's own bone marrow derived...
-
Aug 28, 2017Company on Schedule for 2018 Commercialization of its Patented CaverstemTM Procedure to Treat Erectile Dysfunction in Patients who do not Respond to Currently Available Treatments
Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today completion of enrollment in the Company's clinical trial assessing safety and efficacy of its CaverstemTM...
-
Jul 25, 2017Company's Unique Stem Cell Nanotechnology Approach Appears to Stimulate Regeneration of Healthy Brain Cells While Selectively Inhibiting Glioma Brain Cancer
Creative Medical Technology Holdings, Inc. (OTCQB:CELZ), a clinical stage stem cell company, announced preclinical data showing exosomes harvested from its patented AmnioStem amniotic fluid stem...
-
Jun 21, 2017Company Expands Intellectual Property Portfolio in Lower Back Pain Indication
Creative Medical Technology Holdings, Inc. (the "Company") (OTCQB:CELZ) announced the filing of intellectual property covering data supporting the use of immune system cells for stimulation of...